Sort
15,842 grants matching “pancreatic cancer”
Training the Next Generation of Surgeon-Scientists in Pancreatology
$166,941Masato Yamamoto · University Of Minnesota · T32 · FY2017 · DK
Targeting cytokine mediated CREB activation in pancreatic cancer
$166,931Nagaraj S. Nagathihalli · University Of Miami School Of Medicine · R21 · FY2017 · CA
Macrocyclic inhibitors of upstream protein activators of the Hedgehog pathway
$166,931Rudi Fasan · University Of Rochester · R21 · FY2014 · CA
Targeting PAK4 for Overcoming Drug Resistance in Pancreatic Cancer
$166,840Asfar S Azmi · Wayne State University · R21 · FY2016 · CA
TISSUE MODELING CORE
$166,744Paul Okunieff · University Of Florida · U54 · FY2021 · CA
Comprehensive Intellectual Property, Reimbursement, and Licensing Strategy for ImCare Biotech's Diagnostic Product Seravue
$166,729Xuanyong Lu · Imcare Biotech, Inc. · SB1 · FY2021 · CA
Mechanisms of Pancreatic Cancer Inhibition by SPARC
$166,669Susan L Cohn · University Of Chicago · R21 · FY2014 · CA
Partial-wave spectroscopic microscopy for the diagnosis of cholangiocarcinoma
$166,650Yang Liu · University Of Pittsburgh At Pittsburgh · R21 · FY2010 · CA
Markers for Risk in Familial Pancreatic Cancer
$166,642Ralph H Hruban · Johns Hopkins University · P50 · FY2007 · CA
Chitosan-based Delivery and Immunopotentiation of Cancer Vaccines
$166,584David Zaharoff · University Of Arkansas At Fayetteville · K22 · FY2010 · CA
Project 2: Enhancing Efficacy of Gemcitabine Nanoparticles in Pancreatic PDX Models
$166,568Edward Kwasi Agyare · Florida Agricultural And Mechanical Univ · U54 · FY2019 · CA
Neoglycosylation Epitopes in Metaplasia and Cancer
$166,562Jeffrey Wade Brown · Washington University · K08 · FY2022 · DK
P3 - Mechanism-Based Use of Chk1 Inhibitors in Pancreas Cancer
$166,496Theodore S Lawrence · University Of Michigan At Ann Arbor · P50 · FY2013 · CA
Project 3 - Improving Therapy for DNA-Damage Deficient Pancreatic Adenocarcinoma
$166,489Brian Matthew Wolpin · Dana-Farber Cancer Inst · P50 · FY2021 · CA
Targeting circulating HSP70 and HSP90 for the treatment of cancer cachexia
$166,452Yi-Ping Li · University Of Texas Hlth Sci Ctr Houston · R21 · FY2021 · AR
New HuR inhibitor against pancreatic cancer EMT and CSCs
$166,388Qi Chen · University Of Kansas Medical Center · R21 · FY2017 · CA
Directional Motility and ERM Scaffolding in Pathfinder Pancreatic Carcinoma Cells
$166,388Kathleen M Mulder · Pennsylvania State Univ Hershey Med Ctr · R21 · FY2015 · CA
Project 4: Model-Based Dosimetry and Imaging for PDT
$166,360Brian William Pogue · Massachusetts General Hospital · P01 · FY2016 · CA
Implementing Prevention of Venous Thromboembolism for Ambulatory Patients with Cancer (PREVenT-APC)
$166,323Karlyn Martin · University Of Vermont & St Agric College · K23 · FY2024 · HL
Core A-Pathology Core
$166,209Huamin Wang · University Of Tx Md Anderson Can Ctr · P01 · FY2024 · CA
BIOBANK CORE
$166,199Sarah P Thayer · University Of Tx Md Anderson Can Ctr · P01 · FY2015 · CA
Vector Core
$166,100Paul B McCray · University Of Iowa · P30 · FY2015 · DK
Epigenetic Regulation of Hemidesmosome Signaling in Pancreatic Cancer
$166,096Andrew Liss · Massachusetts General Hospital · R03 · FY2020 · CA
Molecularly guided multimodal theranostics for breast cancer
$166,052Amit Joshi · Baylor College Of Medicine · R01 · FY2010 · CA
Targeting CDK4/6 as an interception strategy for intraductal papillary mucinous neoplasia
$166,037Jonathan Robert Weitz · University Of California, San Diego · K01 · FY2025 · CA